🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,522 results for “solution” Clear

  1. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    The George Institute

    IgA nephropathy

    approved small molecule active

    1 trial

  2. Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  3. VYEPTI 100 mg concentrate for solution for infusion

    H. Lundbeck A/S

    Chronic Migrane, Migrane, Medication Overuse Headache

    approved small molecule active

    1 trial

  4. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  5. Vabysmo 120 mg/mL solution for injection in pre-filled syringe

    The George Institute

    SUBRETINAL HYPERREFLECTIVE MATERIAL

    approved small molecule active

    1 trial

  6. Vyvgart 20 mg/mL concentrate for solution for infusion

    The George Institute

    Patients affected by generalized myasthenia gravis

    approved small molecule active

    1 trial

  7. Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    approved small molecule active

    1 trial

  8. Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen

    Lacuna Pharma Pty Ltd

    Adipositas

    approved small molecule active

    1 trial

  9. Wegovy 2.4 mg solution for injection in pre-filled pen

    The George Institute

    obstructive sleep apnea

    approved small molecule active

    1 trial

  10. Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  11. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  12. Xolair 75 mg solution for injection in pre-filled syringe

    Pari Pharma GmbH

    Well controlled severe allergic asthma

    approved small molecule active

    1 trial

  13. Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial

  14. ZYNRELEF 200Mg-6Mg Extended-Release Solution

    Heron Therapeutics

    Post Operative Pain, Acute

    approved small molecule active

    1 trial

  15. Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione

    Verona Pharma Ireland Limited

    Patients with currently remitted depressive disorders.

    approved small molecule active

    1 trial

  16. 0.1% bromfenac ophthalmic solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule completed

    1 trial

  17. 25% Carbohydrate solution (CHO drinking)

    Hospital Authority, Hong Kong

    Type2diabetes

    other completed

    1 trial

  18. A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).

    The First People's Hospital of Lianyungang

    Neuromuscular Blockade

    small molecule completed

    1 trial

  19. Dextrometropine and 0.9% sodium chloride solution

    The First People's Hospital of Lianyungang

    Cataract

    small molecule active

    1 trial

  20. Eefooton oral solution

    Hospital Authority, Hong Kong

    Chronic Kidney Diseases

    other completed

    1 trial

  21. Hydrogen Peroxide 3 % Topical Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Warts

    small molecule active

    1 trial

  22. Lactated ringers solution

    The First People's Hospital of Lianyungang

    Pancreatitis, Chronic

    small molecule completed

    1 trial

  23. Lidocaine Hydrochloride 2% Injection Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    small molecule completed

    1 trial

  24. Lugol's Solution (1.5%)

    Hospital Authority, Hong Kong

    Esophageal Squamous Cell Neoplasm

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources